Drugs / Exacyl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02403596 | Oct 2015 → Aug 2017 | — | University Hospital, Brest | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01940692 Comparator | Jul 2014 → Nov 2015 | osteoarthritis | Ziekenhuis Oost-Limburg | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exacyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02403596 ↗ |
| Route | Intravenous | “intravenous administration of 1.5g Exacyl preoperatively” NCT01940692 ↗ |